Oruka Therapeutics, Inc. (ORKA) revealed Loss for fourth quarter of -$25.78 million
The company's earnings totaled -$25.78 million, or -$0.49 per share. This compares with -$83.72 million, or -$3.87 per share, last year.
Oruka Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$25.78 Mln. vs. -$83.72 Mln. last year.
-EPS: -$0.49 vs. -$3.87 last year.
For comments and feedback: editorial@rttnews.com